Active substance
Varicella virus vaccine live
- SFDA 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| VARIVAX 1350 PFU VIAL | 1350 PFU/ml | Powder and solvent for suspension for injection · Intramuscular and intravenous use | 1 Vial | SAR 152.10 | Biological · Prescription | MERCK SHARP & DOHME | Valid |
Indications — CHI Daman Drug Formulary
ADULT IMMUNIZATION; CHICKENPOX (VARICELLA); MATERNAL AND CHILD HEALTHCARE- IMMUNIZATION FOR MOTHER AND CHILD; RENAL TRANSPLANT; TRAVEL IMMUNIZATION
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.